Staff
-
ProfessorToru OgaToru Oga
-
Associate ProfessorYoshihiro KobashiYoshihiro Kobashi
-
Assistant ProfessorKoji KuroseKoji Kurose
-
InstructorHitomi IkegamiHitomi Ikegami
-
InstructorSouichirou YamauchiSouichirou Yamauchi
-
InstructorNobuaki TajimaNobuaki Tajima
-
InstructorChisato TamadaChisato Tamada
-
InstructorGou TanimukaiGou Tanimukai
We provide patient-friendly medical service. Respiratory diseases that we encounter vary, including lung cancer, respiratory tract infections, chronic obstructive pulmonary disease (COPD), allergic diseases such as asthma, interstitial lung diseases, sleep-disordered breathing, and respiratory failure. The number of patients with respiratory diseases is huge, and they affect patients’ lives as well as health-related quality of life (HRQOL). Professional knowledge and techniques are necessary to confront these diseases and the related-issues, and, accordingly, we have various specialists covering a broad respiratory field to meet patients’ requests as well as to nurture a research mind. Thus, we have established a highly-developed medicine appropriate for a university hospital, which is also useful for the education of medical students and doctors, and for advanced research.
Our research themes include: 1) Basic and clinical research for asthma, specifically, to develop novel immunotherapy for specific allergens, and to reveal the role of IL-5 in pathogenesis of asthma; 2) Immunological analysis of interstitial pneumonitis; 3) Development of novel immunotherapy and biomarkers for cancer including collaborative work with Prof. Oka in the Department of Immuno-Oncology; 4) Analysis of the pathogenesis and development of novel diagnostic and therapeutic techniques in mycobacterial infection; and 5) Outcome research in respiratory diseases. Regarding the outcome research, we have newly unraveled the ways and the significance in evaluating patient-reported outcomes such as dyspnea and HRQOL, and physiological outcomes such as pulmonary function and exercise capacity especially in COPD, which have had significant impacts on disease management, clinical guidelines and clinical trials.